Catastrophic antiphospholipid syndrome associated with malignancies (case report and review of the literature)

Lupus

Volumn 16, Issue 1, 2007, Pages 59-64

  Ideguchi, H ^a   Ohno, Shigeru ^a   Ueda, A ^b   Ishigatsubo, Y ^b  

^a YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^b YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Catastrophic antiphospholipid syndrome; Malignancies; Ovarian cancer; Recurrent cerebral infarctions; Trousseau's syndrome

Indexed keywords

ANTICOAGULANT AGENT; BETA2 GLYCOPROTEIN 1 ANTIBODY; CARBOPLATIN; CARDIOLIPIN ANTIBODY; DOCETAXEL; HEPARIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; PHOSPHOLIPID ANTIBODY; PROSTAGLANDIN; PROTEIN C; PROTEIN S; WARFARIN;

ADULT; ANAMNESIS; ANTIPHOSPHOLIPID SYNDROME; BRAIN INFARCTION; CASE REPORT; CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME; CLINICAL FEATURE; DEEP VEIN THROMBOSIS; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE COURSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HEMATOLOGIC MALIGNANCY; HEMATURIA; HUMAN; LABORATORY TEST; LUNG EMBOLISM; OVARY ADENOCARCINOMA; PRIORITY JOURNAL; REVIEW; TERMINAL DISEASE; THROMBOEMBOLISM; TROUSSEAU SYNDROME;

ADENOCARCINOMA, CLEAR CELL; ADOLESCENT; ADULT; AGED; ANTICOAGULANTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANTIPHOSPHOLIPID SYNDROME; CARBOPLATIN; CEREBRAL HEMORRHAGE; CEREBRAL INFARCTION; FATAL OUTCOME; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; NEOPLASMS, UNKNOWN PRIMARY; OVARIAN NEOPLASMS; PALLIATIVE CARE; PARANEOPLASTIC SYNDROMES; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; PULMONARY EMBOLISM; TAXOIDS; THROMBOPHILIA; THROMBOPHLEBITIS; WARFARIN;

EID: 33846626038     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203306073166     Document Type: Review

References (35)

1. Wilson WA, Gharavi AE, Koike T et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999; 42: 1309-1311.
2. Asherson RA. A "primary" antiphospholipid syndrome? J Rheumatol 1988; 15: 1742-1746.
3. Pierangeli SS, Girardi G, Vega-Ostertag M, Liu X, Espinola RG, Salmon J. Requirement of activation of complement C3 and C5 for antiphospholipid antibody-mediated thrombophilia. Arthritis Rheum 2005; 52: 2120-2124.
4. Asherson RA. The catastrophic antiphospholipid syndrome. J Rheumatol 1992; 19: 508-512.
5. Asherson RA. Multiorgan failure and antiphospholipid antibodies: the catastrophic antiphospholipid (Asherson's) syndrome. Immunobiology 2005; 210: 727-733.
6. Cervera R, Piette JC, Font J et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 2002; 46: 1019-1027.
7. Asherson RA, Cervera R, de Groot PG et al. Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus 2003; 12: 530-534.
8. Rickles FR, Edwards RL. Activation of blood coagulation in cancer: Trousseau's syndrome revisited. Blood 1983; 62: 14-31.
9. Rickles FR, Levine M, Edwards RL. Hemostatic alterations in cancer patients. Cancer Metastasis Rev 1992; 11: 237-248.
10. Tasi SH, Juan CJ, Dai MS, Kao WY. Trousseau's syndrome related to adenocarcinoma of the colon and cholangiocarcinoma. Eur J Neurol 2004; 11: 493-496.
11. Sallah S, Wan JY, Nguyen NP. Venous thrombosis in patients with solid tumors: determination of frequency and characteristics. Thromb Haemost 2002; 87: 575-579.
12. Zuckerman E, Toubi E, Golan TD et al. Increased thromboembolic incidence in anti-cardiolipin-positive patients with malignancy. Br J Cancer 1995; 72: 447-451.
13. Gomez-Puerta JA, Cervera R, Espinosa G et al. Antiphospholipid antibodies associated with malignancies: clinical and pathological characteristics of 120 patients. Semin Arthritis Rheum 2006; 35: 322-332.
14. Egan RM, Munn RK. Catastrophic antiphospholipid antibody syndrome presenting with multiple thromboses and sites of avascular necrosis. J Rheumatol 1994; 21: 2376-2379.
15. Ruffatti A, Aversa S, Del Ross T, Tonetto S, Fiorentino M, Todesco S. Antiphospholipid antibody syndrome associated with ovarian cancer. A new paraneoplastic syndrome? J Rheumatol 1994; 21: 2162-2163.
16. Bessis D, Sotto A, Viard JP, Berard M, Ciurana AJ, Boffa MC. Trousseau's syndrome with nonbacterial thrombotic endocarditis: pathogenic role of antiphospholipid syndrome. Am J Med 1995; 98: 511-513.
17. Keung YK, Cobos E, Meyerrose GE, Roberson GH. Progressive thrombosis after treatment of diffuse large cell non-Hodgkin's lymphoma and concomitant lupus anticoagulant. Leuk Lymphoma 1996; 20: 341-345.
18. Messiaen T, Lefebvre C, Lambert M. Case report: thoracic aorta thrombus with systemic embolization: a rare paraneoplastic antiphospholipid syndrome? Am J Med Sci 1996; 312: 303-305.
19. Onida P, Tresoldi M, Rugarli C. Anti-phospholipid-antibody syndrome associated with peripheral T-cell lymphoma. Am J Hematol 1997; 55: 167-168.
20. Piette JC, Amoura Z, Foucher-Lavergne A. "Catastrophic" diagnosis of the antiphospholipid syndrome. Ann Intern Med 1999; 131: 798-799.
21. Yoshida J, Iwai T, Mayumi T et al. [A patient operated for occlusion of the superior mesenteric artery]. Nippon Geka Gakkai Zasshi 1999; 100: 228-230.
22. Soltesz P, Szekanecz Z, Vegh J et al. Catastrophic antiphospholipid syndrome in cancer. Haematologia (Budap) 2000; 30: 303-311.
23. Katsuoka H, Mimori Y, Kohriyama T et al. [An autopsy case of catastrophic antiphospholipid syndrome presenting with recurrent multiple cerebral infarction associated with lung cancer]. No To Shinkei 2000; 52: 64-69.
24. Yamamoto T, Ito M, Nagata S et al. Catastrophic exacerbation of antiphospholipid syndrome after lung adenocarcinoma biopsy. J Rheumatol 2000; 27: 2035-2037.
25. Aranguren A, Perez-Salazar M, Paramo JA, Zozaya J, Rocha E. Antiphospholipid antibodies, portal and mesenteric thrombosis and carcinoid tumor: a case report. Thromb Haemost 2001; 86: 1334.
26. Asherson RA, Cervera R, Piette JC et al. Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients. Medicine (Baltimore) 2001; 80: 355-377.
27. Espiritu JD, Creer MH, Miklos AZ, Bajaj MS. Fatal tumor thrombosis due to an inferior vena cava leiomyosarcoma in a patient with antiphospholipid antibody syndrome. Mayo Clin Proc 2002; 77: 595-599.
28. Langer F, Eifrig B, Marx G, Stork A, Hegewisch-Becker S, Hossfeld DK. Exacerbation of antiphospholipid antibody syndrome after treatment of localized cancer: a report of two cases. Ann Hematol 2002; 81: 727-731.
29. Moll S, Kudrik FJ, Thomas DB. Catastrophic antiphospholipid antibody syndrome. Am J Hematol 2003; 72: 278-279.
30. Orsino A, Schneider R, DeVeber G et al. Childhood acute myelomonocytic leukemia (AML-M4) presenting as catastrophic antiphospholipid antibody syndrome. J Pediatr Hematol Oncol 2004; 26: 327-330.
31. Ozaki M, Ogata M, Yokoyama T, Kawasaki T, Shigematsu A, Sata T. Prevention of thrombosis with prostaglandin E1 in a patient with catastrophic antiphospholipid syndrome. Can J Anaesth 2005; 52: 143-147.
32. Cervera R, Font J, Gomez-Puerta JA et al. Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome. Ann Rheum Dis 2005; 64: 1205-1209.
33. Erkan D, Yazici Y, Peterson MG, Sammaritano L, Lockshin MD. A cross-sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome. Rheumatology (Oxford) 2002; 41: 924-929.
34. Bucciarelli S, Espinosa G, Cervera R et al. Mortality in the catastrophic antiphospholipid syndrome: Causes of death and prognostic factors in a series of 250 patients. Arthritis Rheum 2006; 54: 2568-2576.
35. Malnick SD, Geltner D, Sthoeger Z. Anticardiolipin antibody associated with renal carcinoma. J Rheumatol 1995; 22: 2007-2008.